Clinical studies sponsored by digital health companies participating in the FDA’s Precertification Pilot Program: A cross-sectional analysis

U.S. Food and Drug Administration. Policy for device software functions and mobile medical applications, 2019, https://www.fda.gov/media/80958/download

Chen CE Harrington RA Desai SA , et al. Characteristics of digital health studies registered in ClinicalTrials.gov. JAMA Intern Med 2019; 179(6): 838–840.

Safavi K Mathews SC Bates DW , et al. Top-funded digital health companies and their impact on high-burden, high-cost conditions. Health Aff 2019; 38(1): 115–123.

U.S. Food and Drug Administration. Developing the software precertification program: summary of learnings and ongoing activities, 2020, https://www.fda.gov/media/142107/download

Lee TT Kesselheim AS . U.S. Food and Drug Administration precertification pilot program for digital health software: weighing the benefits and risks. Ann Intern Med 2018; 168(10): 730–732.

Bartlett VL Dhruva SS Shah ND , et al. Feasibility of using real-world data to replicate clinical trial evidence. JAMA Netw Open 2019; 2(10): e1912869.

Wyatt KD Poole LR Mullan AF , et al. Clinical evaluation and diagnostic yield following evaluation of abnormal pulse detected using Apple Watch. J Am Med Inform Assoc 2020; 27(9): 1359–1363.